BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19106394)

  • 1. Pharmacological intervention for prevention of left ventricular remodeling and improving prognosis in myocardial infarction.
    Ishii H; Amano T; Matsubara T; Murohara T
    Circulation; 2008 Dec; 118(25):2710-8. PubMed ID: 19106394
    [No Abstract]   [Full Text] [Related]  

  • 2. Erythropoietin in cardioprotection: does it have a future or is it all in the past?
    Mehta JL
    Cardiovasc Res; 2008 Sep; 79(4):549-50. PubMed ID: 18583337
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of PI3Kgamma inhibition using AS-605240 in acute myocardial infarction.
    Seropian IM; Toldo S; Abbate A; Mezzaroma E; Van Tassell BW
    Circ Res; 2010 Jul; 107(2):e5; author reply e6-7. PubMed ID: 20651289
    [No Abstract]   [Full Text] [Related]  

  • 4. Secondary prevention of myocardial infarction: new horizons for pharmacotherapy. Introduction.
    Taylor SH
    Eur Heart J; 1996 Dec; 17 Suppl F():1-2. PubMed ID: 8960441
    [No Abstract]   [Full Text] [Related]  

  • 5. Causes, consequences, and amelioration of late adverse ventricular remodeling after myocardial infarction.
    Zaman AK; Sobel BE
    Coron Artery Dis; 2012 May; 23(3):221-2. PubMed ID: 22336659
    [No Abstract]   [Full Text] [Related]  

  • 6. [Predictive factors of ventricular remodeling following myocardial infarction].
    Lakhdhar R; Selmi K; Mokaddem A; Belhani A
    Tunis Med; 1999; 77(8-9):415-22. PubMed ID: 10611818
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiovascular effects of aldosterone and post-acute myocardial infarction pathophysiology.
    Cohn JN; Colucci W
    Am J Cardiol; 2006 May; 97(10A):4F-12F. PubMed ID: 16698330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of Trimetazidine upon ventricular remodeling and GLUT4 in diabetic rats after myocardial infarction].
    Zhang RY; Yu P; Wang F; Shen JX; Wang YM
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(18):1240-5. PubMed ID: 19595176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase inhibition and adverse remodeling during healing after myocardial infarction.
    Jugdutt BI
    Circulation; 2007 Jan; 115(3):288-91. PubMed ID: 17242292
    [No Abstract]   [Full Text] [Related]  

  • 10. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy.
    Dill T; Schächinger V; Rolf A; Möllmann S; Thiele H; Tillmanns H; Assmus B; Dimmeler S; Zeiher AM; Hamm C
    Am Heart J; 2009 Mar; 157(3):541-7. PubMed ID: 19249426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is stress hyperglycaemia a prognostic marker of left ventricular remodelling after first anterior myocardial infarction?
    Papadopoulos CE; Karvounis HI; Parharidis GE
    Eur Heart J; 2007 Nov; 28(22):2821; author reply 2821-2. PubMed ID: 17959617
    [No Abstract]   [Full Text] [Related]  

  • 12. Heart-rate reduction and beta-blockade in early post-infarction cardiac remodelling.
    Goldstein RE; Haigney MC
    Cardiovasc Res; 2008 Jul; 79(1):5-6. PubMed ID: 18487234
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter by Csont and Ferdinandy regarding article, "Biglycan is required for adaptive remodeling after myocardial infarction".
    Csont T; Ferdinandy P
    Circulation; 2008 Oct; 118(15):e521; author reply e522. PubMed ID: 18838570
    [No Abstract]   [Full Text] [Related]  

  • 14. [Inhibitor of left ventricular remodeling].
    Kurabayashi M
    Nihon Rinsho; 2011 Nov; 69 Suppl 9():246-51. PubMed ID: 22724210
    [No Abstract]   [Full Text] [Related]  

  • 15. Potential antiapoptotic activity of aldosterone antagonists in postinfarction remodeling.
    Biondi-Zoccai GG; Abbate A; Baldi A
    Circulation; 2003 Jul; 108(4):e26. PubMed ID: 12885738
    [No Abstract]   [Full Text] [Related]  

  • 16. [New therapeutic goals--new drugs in heart failure treatment].
    Skóra E; Bilińska ZT
    Kardiol Pol; 2007 Nov; 65(11):1368-75. PubMed ID: 18058588
    [No Abstract]   [Full Text] [Related]  

  • 17. [Left ventricular remodeling after acute myocardial infarction].
    Takano H; Takayama M
    Nihon Rinsho; 2003 May; 61 Suppl 5():758-66. PubMed ID: 12809031
    [No Abstract]   [Full Text] [Related]  

  • 18. Periostin and myocardial repair, regeneration, and recovery.
    Dorn GW
    N Engl J Med; 2007 Oct; 357(15):1552-4. PubMed ID: 17928607
    [No Abstract]   [Full Text] [Related]  

  • 19. Infarct haemorrhage detected by cardiac magnetic resonance imaging: are we seeing the latest culprit in adverse left ventricular remodelling?
    Kwong RY; Pfeffer MA
    Eur Heart J; 2009 Jun; 30(12):1431-3. PubMed ID: 19460842
    [No Abstract]   [Full Text] [Related]  

  • 20. Optimizing pharmacotherapy for limiting cardiovascular remodeling a matter of timing therapy to match biology.
    Jugdutt BI
    J Am Coll Cardiol; 2011 May; 57(20):2029-30. PubMed ID: 21565640
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.